The cochlear implant (CI) is the first effective treatment for deafness and severe losses in
hearing. As such, the CI is now widely regarded as one of the great advances in modern …

Otitis media (OM) is an inflammation of the middle ear associated with infection. Despite
appropriate therapy, acute OM (AOM) can progress to chronic suppurative OM (CSOM) …

… TJ BALKANY, AV HODGES, CA BUCHMAN, WM LUXFORD, CH PILLSBURY, PS ROLAND,
JK SHALLOP, DD BACKOUS, D FRANZ, JM GRAHAM, B HIRSCH, M LUNTZ, JK NIPARKO, J …

Objectives/Hypothesis: Cochlear implantation (CI) carries with it the potential risk for vestibular
system insult or stimulation with resultant dysfunction. As candidate profiles continue to …

Mutations in GJB2, encoding gap junction beta 2 protein (connexin 26), are responsible for
the commonest form of non-syndromic recessive deafness in many populations. It has been …

Most patients with neurofibromatosis type 2 (NF2) are totally deaf after removal of their
bilateral acoustic neuromas. Twenty‐five patients with neurofibromatosis type 2 have been …

Objective: This study was designed to test the hypothesis that partial hearing conservation is
attainable after cochlear implantation with a long perimodiolar electrode. Surgical strategies …

Objective: To describe clinical experiences with multichannel cochlear implantation in
children with inner ear malformations, including surgical indications and techniques, imaging …

Objectives/Hypothesis: To identify the incidence of and common causes for cochlear
implant revision. Study Design: Retrospective case series. Methods: Operative records were …

The treatment of glomus jugulare tumors is controversial. Changes in the surgical treatment
of glomus jugulare tumors at The House Ear Clinic have allowed complete resection in 85% …